Nath Bio-Genes (India) consolidated net profit rises 11.78% in the June 2025 quarter
Net profit of Nath Bio-Genes (India) rose 11.78% to Rs 37.28 crore in the quarter ended June 2025 as against Rs 33.35 crore during the previous quarter ended June 2024. Sales rose 16.33% to Rs 283.70 crore in the quarter ended June 2025 as against Rs 243.88 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended | ||
| Jun. 2025 | Jun. 2024 | % Var. | |
| Sales | 283.70 | 243.88 | 16 |
| OPM % | 13.49 | 14.98 | - |
| PBDT | 36.86 | 34.43 | 7 |
| PBT | 35.88 | 33.60 | 7 |
| NP | 37.28 | 33.35 | 12 |